PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹4,720 Cr | ₹4,559 Cr | ₹5,505 Cr | ₹4,023 Cr | ₹2,910 Cr |
What is the latest Total Debt ratio of PIRAMAL PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹4,720 Cr |
| Mar2024 | ₹4,559 Cr |
| Mar2023 | ₹5,505 Cr |
| Mar2022 | ₹4,023 Cr |
| Mar2021 | ₹2,910 Cr |
How is Total Debt of PIRAMAL PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,720 Cr | 3.54 | |
| Mar2024 | ₹4,559 Cr | -17.18 | |
| Mar2023 | ₹5,505 Cr | 36.82 | |
| Mar2022 | ₹4,023 Cr | 38.25 | |
| Mar2021 | ₹2,910 Cr | - | |
Compare Total Debt of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹20,330.1 Cr | -4.1% | 0.9% | -25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -4.1% |
0.9% |
-25.3% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses